JP2022513043A5 - - Google Patents
Info
- Publication number
- JP2022513043A5 JP2022513043A5 JP2021526460A JP2021526460A JP2022513043A5 JP 2022513043 A5 JP2022513043 A5 JP 2022513043A5 JP 2021526460 A JP2021526460 A JP 2021526460A JP 2021526460 A JP2021526460 A JP 2021526460A JP 2022513043 A5 JP2022513043 A5 JP 2022513043A5
- Authority
- JP
- Japan
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024199831A JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
| JP2026003911A JP2026065087A (ja) | 2018-11-14 | 2026-01-13 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767431P | 2018-11-14 | 2018-11-14 | |
| US62/767,431 | 2018-11-14 | ||
| US201962902334P | 2019-09-18 | 2019-09-18 | |
| US62/902,334 | 2019-09-18 | ||
| PCT/US2019/061567 WO2020102603A1 (en) | 2018-11-14 | 2019-11-14 | Engineered cd25 polypeptides and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024199831A Division JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022513043A JP2022513043A (ja) | 2022-02-07 |
| JPWO2020102603A5 JPWO2020102603A5 (https=) | 2023-06-14 |
| JP2022513043A5 true JP2022513043A5 (https=) | 2023-06-14 |
| JP7695881B2 JP7695881B2 (ja) | 2025-06-19 |
Family
ID=70731914
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526460A Active JP7695881B2 (ja) | 2018-11-14 | 2019-11-14 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
| JP2024199831A Pending JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
| JP2026003911A Pending JP2026065087A (ja) | 2018-11-14 | 2026-01-13 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024199831A Pending JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
| JP2026003911A Pending JP2026065087A (ja) | 2018-11-14 | 2026-01-13 | 操作されたｃｄ２５ポリペプチドおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12441803B2 (https=) |
| EP (1) | EP3880698A4 (https=) |
| JP (3) | JP7695881B2 (https=) |
| CN (1) | CN113646330A (https=) |
| CA (1) | CA3120102A1 (https=) |
| WO (1) | WO2020102603A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109053882B (zh) * | 2018-08-28 | 2019-08-23 | 东莞市朋志生物科技有限公司 | 一种ns1蛋白的结合蛋白以及应用 |
| CA3120096A1 (en) | 2018-11-14 | 2020-05-22 | Rubryc Therapeutics, Inc. | Cd25 antibodies |
| EP3976083A4 (en) * | 2019-05-31 | 2023-07-12 | iBio, Inc. | MACHINE LEARNING BASED DEVICE FOR THE DEVELOPMENT OF MESO-SCALE PEPTIDES, AND METHOD AND SYSTEM THEREOF |
| WO2021119261A1 (en) * | 2019-12-10 | 2021-06-17 | Homodeus, Inc. | Generative machine learning models for predicting functional protein sequences |
| CN116745318A (zh) * | 2020-11-10 | 2023-09-12 | 斯克里普斯研究学院 | 用于阿片样物质治疗的抗体 |
| US20240096443A1 (en) * | 2020-12-01 | 2024-03-21 | Ibio, Inc. | Generalized Scaffolds for Polypeptide Display and Uses Thereof |
| US20250179196A1 (en) * | 2021-07-30 | 2025-06-05 | Janssen Biotech, Inc. | Materials and methods of making or using il-23r binding proteins |
| CN114384245B (zh) * | 2022-03-24 | 2022-06-24 | 江苏美克医学技术有限公司 | 新型冠状病毒s-rbd蛋白和n蛋白双表位识别的联检试剂盒及其应用 |
| WO2025235413A1 (en) * | 2024-05-05 | 2025-11-13 | Duke University | Compositions targeting cancer antigens and methods of use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279057C (zh) * | 2002-07-12 | 2006-10-11 | 马菁 | 重组的抗cd25单克隆抗体、其编码序列及应用 |
| US7438907B2 (en) | 2002-11-15 | 2008-10-21 | Genmab A/S | Human monoclonal antibodies against CD25 |
| CN107129524B (zh) | 2007-09-25 | 2023-11-21 | 田园温室气体研究有限公司 | 用于抑制微生物细胞的疫苗和疫苗组分 |
| WO2011051327A2 (en) | 2009-10-30 | 2011-05-05 | Novartis Ag | Small antibody-like single chain proteins |
| EA201892619A1 (ru) * | 2011-04-29 | 2019-04-30 | Роше Гликарт Аг | Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2 |
| WO2014028776A1 (en) | 2012-08-15 | 2014-02-20 | Zyngenia, Inc. | Monovalent and multivalent multispecific complexes and uses thereof |
| FI2970398T3 (fi) | 2013-03-13 | 2024-08-06 | Us Health | Rsv f -prefuusioproteiineja ja niiden käyttö |
| EP2970486B1 (en) | 2013-03-15 | 2018-05-16 | Xencor, Inc. | Modulation of t cells with bispecific antibodies and fc fusions |
| WO2016040110A1 (en) | 2014-09-10 | 2016-03-17 | The University Of Connecticut | Identification of immunologically protective neo-epitopes for the treatment of cancers |
| WO2016179212A1 (en) | 2015-05-05 | 2016-11-10 | Albert Einstein College Of Medicine, Inc. | Antibody therapeutics against filovirus infections and uses thereof |
| WO2018089829A1 (en) * | 2016-11-10 | 2018-05-17 | Fortis Therapeutics, Inc. | Cd46-specific effector cells and uses thereof |
| US11879014B2 (en) * | 2017-03-17 | 2024-01-23 | Tusk Therapeutics Ltd. | Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody |
| CN110856446A (zh) * | 2017-04-18 | 2020-02-28 | 阿法姆海外股份有限公司 | 抗pd-l1抗体及其用途 |
| JP7464530B2 (ja) * | 2018-03-28 | 2024-04-09 | ブリストル－マイヤーズ スクイブ カンパニー | インターロイキン－２／インターロイキン－２受容体アルファ融合タンパク質および使用方法 |
| CA3120096A1 (en) | 2018-11-14 | 2020-05-22 | Rubryc Therapeutics, Inc. | Cd25 antibodies |
| EP3976083A4 (en) | 2019-05-31 | 2023-07-12 | iBio, Inc. | MACHINE LEARNING BASED DEVICE FOR THE DEVELOPMENT OF MESO-SCALE PEPTIDES, AND METHOD AND SYSTEM THEREOF |
-
2019
- 2019-11-14 EP EP19885972.0A patent/EP3880698A4/en active Pending
- 2019-11-14 CN CN201980088633.3A patent/CN113646330A/zh active Pending
- 2019-11-14 CA CA3120102A patent/CA3120102A1/en active Pending
- 2019-11-14 WO PCT/US2019/061567 patent/WO2020102603A1/en not_active Ceased
- 2019-11-14 JP JP2021526460A patent/JP7695881B2/ja active Active
-
2021
- 2021-05-13 US US17/320,118 patent/US12441803B2/en active Active
-
2024
- 2024-11-15 JP JP2024199831A patent/JP2025026923A/ja active Pending
-
2026
- 2026-01-13 JP JP2026003911A patent/JP2026065087A/ja active Pending